Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD

Slides:

Advertisements

Similar presentations

Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.

Advertisements

Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global,

Spinal Cord and Peripheral Nerve Stimulation Techniques for Neuropathic Pain Oscar A. de Leon-Casasola, MD Journal of Pain and Symptom Management Volume.

Comparison of the Constipation Assessment Scale and Plain Abdominal Radiography in the Assessment of Constipation in Advanced Cancer Patients Kittiphon.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

One-Year rTMS Treatment for Refractory Trigeminal Neuralgia

Chronic Pain Management in Older Adults: Special Considerations

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Neurotoxicity from Chronic Opioid Therapy After Successful Palliative Treatment for Painful Bone Metastases Andrew Broadbent, BMedSc, MBChB, FRACP, FAChPM,

Switching from Reservoir to Matrix Systems for the Transdermal Delivery of Fentanyl: A Prospective, Multicenter Pilot Study in Outpatients with Chronic.

Clinical Trial Results with OROS® Hydromorphone

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Wen Jing Chung, MD, MS, Gregory H. Pharo, DO

An Assessment of the Safety, Eff icacy, and Acceptability of Intranasal Fentanyl Citrate in the Management of Cancer-Related Breakthrough Pain Giovambattista.

Effects of High Dose Opioids and Sedatives on Survival in Terminally Ill Cancer Patients Tatsuya Morita, MD, Junichi Tsunoda, MD, Satoshi Inoue, MD,

Family Members' Experiences Caring for Patients With Advanced Head and Neck Cancer Receiving Tube Feeding: A Descriptive Phenomenological Study Jamie.

An Effective Treatment of Severe Complex Regional Pain Syndrome Type 1 in a Child Using High Doses of Intrathecal Ziconotide Michael Stanton-Hicks, MD,

Chronic Pain Management in Older Adults: Special Considerations

A Case Series of Patients Using Medicinal Marihuana for Management of Chronic Pain Under the Canadian Marihuana Medical Access Regulations Mary E. Lynch,

Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief Giovambattista Zeppetella, FRCP Journal.

The Value of a Symptom Cluster of Fatigue, Dyspnea, and Cough in Predicting Clinical Outcomes in Lung Cancer Survivors Andrea L. Cheville, MD, MSCE,

A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced.

Patient-Controlled Analgesia With Intravenous L-Methadone in a Child With Cancer Pain Refractory to High-Dose Morphine Rainer Sabatowski, MD, Stefan.

What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study Catherine Malia, MSc, Michael I. Bennett, MB, ChB,

Samy A. Alsirafy, MBBCh, MSc, MD, ABHPM, Dip Pall Med

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

Bettina N. Nielsen, MSc, Gitte Aagaard, RN, Steen W

Symptomatic Therapy of Dyspnea with Strong Opioids and Its Effect on Ventilation in Palliative Care Patients Katri Elina Clemens, MD, PhD, Eberhard Klaschik,

Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative.

David M. Dosa, MD, MPH, David D

Exploring the Meaning of Chronic Rejection After Lung Transplantation and Its Impact on Clinical Management and Caregiving Mi-Kyung Song, PhD, RN, Annette.

Delirium in Terminal Cancer

Jean-Pierre Van Buyten, MD Journal of Pain and Symptom Management

Fentanyl-Induced Neurotoxicity and Paradoxic Pain

An Open-Label, Multi-Dose Efficacy and Safety Study of Intramuscular Tetrodotoxin in Patients with Severe Cancer-Related Pain Neil A. Hagen, MD, FRCPC,

One-Year rTMS Treatment for Refractory Trigeminal Neuralgia

Transdermal Fentanyl for Chronic Pain in AIDS

Temporary Sympathectomy in the Treatment of Chronic Refractory Angina

The Opioid Rotation Ratio From Transdermal Fentanyl to “Strong” Opioids in Patients With Cancer Pain Akhila Reddy, MD, Sriram Yennurajalingam, MD, MS,

David Clark, PhD, Michael Wright, PhD

Redefining Appropriate Treatment Expectations

Treatment of Cancer Pain with Noninvasive Brain Stimulation

Characterization of the early pharmacodynamic profile of oral methadone for cancer- related breakthrough pain: a pilot study Kim Fisher, PhD, Carla Stiles,

Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD

A Comparative Review of Palliative Care Development in Six Countries Represented by the Middle East Cancer Consortium (MECC) Amanda Bingley, PhD, David.

Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms Anna-Liisa Kautio, MD, Maija Haanpää, MD, PhD, Tiina Saarto, MD, PhD, Eija.

The Role of a Low-Dose Ketamine-Midazolam Regimen in the Management of Severe Painful Crisis in Patients With Sickle Cell Disease Qutaiba A. Tawfic,

The effect of transdermal fentanyl treatment on serum cortisol concentrations in patients with non-cancer pain Emine Ozyuvaci, MD, Nergis Yanmaz Alnigenis,

Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD

Strategies in Pain Management

Cancer Pain Assessment and Management Recommendations by Hospice Nurses Paul A Sloan, MD, Barbara L Vanderveer, BSN, Janet S Snapp, BSN, Mitzi Johnson,

Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer.

Prolonged Treatment with Transdermal Fentanyl in Neuropathic Pain

Methadone Analgesia in Cancer Pain Patients on Chronic Methadone Maintenance Therapy Paolo L Manfredi, MD, Gilbert R Gonzales, Andrea L Cheville, Craig.

Improving Access to Opioid Analgesics for Palliative Care in India

Cancer Pain Education Journal of Pain and Symptom Management

Transdermal Fentanyl in Opioid-Naive Cancer Pain Patients

Calibration of Quality-Adjusted Life Years for Oncology Clinical Trials Jeff A. Sloan, PhD, Daniel J. Sargent, PhD, Paul J. Novotny, MS, Paul A. Decker,

Gertrud Andersen, MD, Lona Christrup, PhD, Per Sjøgren, MD

Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients? Filipa Tavares, MD Journal of Pain and Symptom.

Comparative Efficacy of Oral Extended-Release Hydromorphone and Immediate- Release Hydromorphone in Patients with Persistent Moderate to Severe Pain: Two.

Long-Term Safety of Oral Transmucosal Fentanyl Citrate for Breakthrough Cancer Pain Richard Payne, MD, Paul Coluzzi, MD, Lowell Hart, MD, Mary Simmonds,

Fentanyl for the Relief of Refractory Breathlessness: A Systematic Review Steffen T. Simon, MD, MSc, Peyla Köskeroglu, Jan Gaertner, MD, Raymond Voltz,

The Asia Pacific Hospice Palliative Care Network

Nathaniel P Katz, MD Journal of Pain and Symptom Management

Botucatu, Brazil: A Regional Community Palliative Care Model

Amy P. Abernethy, MD Journal of Pain and Symptom Management

Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain Deirdre M Neighbors, BA, Timothy J Bell,

Efficacy and Safety of a Six-Hour Continuous Overlap Method for Converting Intravenous to Transdermal Fentanyl in Cancer Pain Renato V. Samala, MD, Rafael.

Use of Pregabalin in the Management of Chronic Uremic Pruritus

Presentation transcript:

A Clinical Evaluation of Transdermal Therapeutic System Fentanyl for the Treatment of Cancer Pain Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD Journal of Pain and Symptom Management Volume 16, Issue 2, Pages 102-111 (August 1998) DOI: 10.1016/S0885-3924(98)00044-X

Fig. 1. Transdermal therapeutic system (TTS) fentanyl conversion for patients receiving chronic oral morphine analgesia Journal of Pain and Symptom Management 1998 16, 102-111DOI: (10.1016/S0885-3924(98)00044-X)

Fig. 2. Transdermal therapeutic system (TTS) fentanyl dose and daily “rescue” morphine dose Journal of Pain and Symptom Management 1998 16, 102-111DOI: (10.1016/S0885-3924(98)00044-X)

Fig. 3. Patient global evaluation of pain relief Journal of Pain and Symptom Management 1998 16, 102-111DOI: (10.1016/S0885-3924(98)00044-X)

Fig. 4. Patient mean (SEM) pain visual analogue scale (0 = least possible pain; 100 = worst possible pain) Journal of Pain and Symptom Management 1998 16, 102-111DOI: (10.1016/S0885-3924(98)00044-X)